BRIEF-Endo evaluating number of options regarding Voltaren gel
March 21 (Reuters) - Endo International PLC :
* Endo provides statement regarding expected FDA approval of generic Voltaren gel product
* Evaluating a number of options regarding Voltaren gel
* To provide more detail on potential financial impact of generic entrant for Voltaren gel no later than q1 2016 earnings presentation Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.